FDA Center heads to take the stage together at CHPA Regulatory Conference
Each year, CHPA’s RSQ Conference unites industry, regulators, and academia to focus on the evolving self-care sector.
CHPA
Illinois expands consumer access to PSE and strengthens support for the system that prevents diversion
"The passage of HB 3087 represents a significant victory for both consumer access and public safety,” said Carlos Gutierrez, vice president of State & Local Government Affairs at CHPA.
CHPA applauds Senate HELP for advancing OMUFA with key wins for self-care; calls for GRAS/E Clarity
The legislation passed out of Committee today includes important provisions to accelerate the development and acceptance of innovative, non-animal testing methods for topically applied products, including sunscreens.
CHPA applauds Senate introduction of OMUFA
Industry calls for clear GRAS/E standards and broader adoption of non-animal testing to advance innovation and safety across all topical OTC products.
CHPA welcomes new board members at June meeting
“Each brings a wealth of leadership experience, strategic insight, and a deep commitment to consumer health and wellness.”
Bipartisan lawmakers relaunch dietary supplement caucus
The congressional caucus will host nonpartisan briefings on supplements, covering science, regulation, and their potential to cut healthcare costs and boost wellness.
CHPA applauds bipartisan SAFE Sunscreen Standards Act
The legislation recognizes sunscreen's vital role in skin cancer prevention and seeks to broaden effective sun protection options for U.S. consumers.
CHPA survey shows strong support for dietary supplement reform
While most consumers trust dietary supplements are safe, there is still room to strengthen further confidence in their safety and awareness of how they are regulated.
Dr. Scott Furness joins CHPA’s senior management team
Dr. Furness joins CHPA after over 25 years at the FDA, where he held several leadership positions.
CHPA submits official comments on Section 232 National Security Investigation of Pharmaceuticals
“These products deliver proven value—every $1 spent on OTC medicines saves over $7 in healthcare costs, totaling $167 billion in annual savings through avoided doctor visits and lower-cost treatment options."
CHPA issues statement on HHS/FDA plans to phase out some synthetic dyes
The FDA and HHS have announced plans to phase out petroleum-based synthetic dyes from the national food supply and replace them with natural ingredients.
Health In Hand Foundation calls for nominations for 2025 U.S. Self-Care Marketing Awards
The awards honor strategic innovation and marketing in OTC medicine, dietary supplements, and OTC medical devices.
CHPA releases statement on FDA plans to end animal testing
“We look forward to working collaboratively with FDA and other stakeholders on this important scientific and regulatory paradigm shift,” says the CHPA.
CHPA lauds lawmakers for urging FDA to safeguard Rx-OTC pathway
“It cannot be emphasized enough how vital expanded access to OTC medicines is to public health, and the Rx-to-OTC switch process has delivered safe, effective, and affordable options for decades.”
Industry groups issue statements on confirmation of Dr. Makary as FDA commissioner
The Senate confirmed Dr. Makary's nomination by a vote of 56-44.
Greg Bradley elected CHPA board chair
Bradley is the president and CEO of Foundation Consumer Healthcare and has been a standing member of CHPA’s board of directors.